Nontuberculous Mycobacteria Infections and Anti–Tumor Necrosis Factor-α Therapy

Patients receiving anti–tumor necrosis factor-α (anti–TNF-α) therapy are at increased risk for tuberculosis and other granulomatous diseases, but little is known about illness caused by nontuberculous mycobacteria (NTM) in this setting. We reviewed the US Food and Drug Administration MedWatch databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Winthrop, Kevin L., Chang, Eric, Yamashita, Shellie, Iademarco, Michael F., LoBue, Philip A.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866401/
https://www.ncbi.nlm.nih.gov/pubmed/19861045
http://dx.doi.org/10.3201/eid1510.090310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2866401/
https://www.ncbi.nlm.nih.gov/pubmed/19861045
http://dx.doi.org/10.3201/eid1510.090310

Ejemplares similares